Omega-3 fatty acids and non-communicable diseases

Chin Med J (Engl). 2003 Mar;116(3):453-8.

Abstract

Objective: To review the relation between dietary omega-3 polyunsaturated fatty acids (omega-3 PUFA) and non-communicable diseases.

Method: Data were collected from scientific journals and conference publications, MEDLINE (1979 - 2002) and current content which included 68 prospective, cross-sectional, case control and dietary-intervention studies. Scientific paper selections were based on the association between omega-3 PUFA and non-communicable diseases.

Results: omega-3 PUFA has beneficial effects on increasing heart rate variability, decreasing the risk of stroke, reducing both systolic and diastolic blood pressure, insulin resistance and glucose metabolism. Long chain omega-3 PUFA has anti-cancer and anti-inflammatory activities. omega-3 PUFA has also been reported to have a beneficial effect on attention-deficit/hyperactivity disorder and schizophrenia, and may be effective in managing depression in adults.

Conclusions: Results from epidemiological and dietary intervention studies have shown that omega-3 PUFA represent powerfully a class of bioactive compounds and that dietary intake of omega-3 PUFA plays a critical role in human health in relation to non-communicable diseases.

Publication types

  • Review

MeSH terms

  • Diabetes Mellitus / therapy
  • Fatty Acids, Omega-3 / administration & dosage*
  • Fatty Acids, Omega-3 / pharmacology
  • Humans
  • Hypertension / prevention & control
  • Inflammation / prevention & control
  • Lipids / blood
  • Mental Disorders / therapy
  • Neoplasms / prevention & control
  • Thrombosis / prevention & control

Substances

  • Fatty Acids, Omega-3
  • Lipids